| scholarly article | Q13442814 |
| P2093 | author name string | L Young | |
| M Wong | |||
| G Panayi | |||
| A Wierzbicki | |||
| B Kirkham | |||
| P Chowienczyk | |||
| S P Oakley | |||
| B Y Jiang | |||
| P2860 | cites work | Aortic distensibility and hypercholesterolaemia | Q67523341 |
| The health assessment questionnaire 1992: status and review | Q67958010 | ||
| Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 | ||
| Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis | Q73374692 | ||
| Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Clinical value of aortic pulse-wave velocity measurement | Q78201086 | ||
| Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 | ||
| Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation | Q78794854 | ||
| The relationship between aortic augmentation index and pulse wave velocity: an invasive study | Q79520138 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis | Q80194544 | ||
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques | Q81926367 | ||
| The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had | Q82132610 | ||
| Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial | Q82690898 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Selective COX-2 inhibition improves endothelial function in coronary artery disease | Q28194726 | ||
| Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c | Q33213855 | ||
| Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients | Q33947313 | ||
| Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? | Q34154410 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity | Q35553196 | ||
| Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis | Q35953268 | ||
| What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. | Q35954625 | ||
| Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis | Q36204149 | ||
| Atherogenic lipid profiles and its management in patients with rheumatoid arthritis | Q36596894 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
| Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy | Q36909397 | ||
| Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 | ||
| Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study | Q43859232 | ||
| Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 | ||
| Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians | Q44170460 | ||
| Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states | Q44616529 | ||
| Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. | Q46632190 | ||
| Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation | Q47209180 | ||
| Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 | ||
| Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. | Q50779374 | ||
| Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. | Q51487622 | ||
| Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. | Q51666662 | ||
| Smallest detectable difference in radiological progression. | Q52909883 | ||
| A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 | ||
| Effect of anti–tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis | Q57307126 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1277-1284 | |
| P577 | publication date | 2008-10-17 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Infliximab improves vascular stiffness in patients with rheumatoid arthritis | |
| P478 | volume | 68 |
| Q88077426 | Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis |
| Q85069915 | Biologics and cardiovascular risk |
| Q38185646 | Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? |
| Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q38260198 | Cardiovascular risk and the use of biologic agents in rheumatoid arthritis |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q33690668 | Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison |
| Q35557952 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease |
| Q38830086 | Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care |
| Q36792775 | Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study |
| Q44973053 | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial |
| Q41686212 | Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System. |
| Q37929160 | Pharmacological modulation of arterial stiffness |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q36311200 | Reduced large elastic artery stiffness with regular aerobic exercise in middle-aged and older adults: potential role of suppressed nuclear factor κ B signalling. |
| Q34098318 | Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy |
| Q60592413 | Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors |
| Q37531480 | Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease |
| Q50133565 | Strategies for Achieving Healthy Vascular Aging |
| Q38519523 | Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. |
| Q35675593 | The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab |
| Q53497020 | The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis. |
| Q53095551 | The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis—a randomized, placebo-controlled pilot trial. |
| Q82367271 | The major determinants of arterial stiffness in Korean patients with rheumatoid arthritis are age and systolic blood pressure, not disease-related factors |
| Q26774555 | Therapeutic modification of arterial stiffness: An update and comprehensive review |
| Q42696887 | Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study |
| Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
| Q37630351 | Vascular effects of biologic agents in RA and spondyloarthropathies |
Search more.